Company BioTime, Inc. Nyse
Equities
US09066L1052
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Products
100.0
%
| 15 | 100.0 % | 9 | 100.0 % | -39.16% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 15 | 100.0 % | 9 | 100.0 % | -39.16% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 17/18/17 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 14/22/14 |
Chief Operating Officer | - | 01/10/01 | |
Gary Hogge
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/18/01 |
Ioana C. Hone
IRC | Investor Relations Contact | - | - |
George Samuel
LAW | General Counsel | 43 | 01/21/01 |
Derek Kelaita
PRN | Corporate Officer/Principal | - | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 01/09/01 |
Brian Culley
CEO | Chief Executive Officer | 53 | 17/18/17 |
Deborah Andrews
BRD | Director/Board Member | 66 | 11/14/11 |
Don Bailey
BRD | Director/Board Member | 78 | 01/20/01 |
Angus Russell
BRD | Director/Board Member | 68 | 09/14/09 |
Michael Mulroy
CHM | Chairman | 58 | 04/14/04 |
Director/Board Member | 67 | 04/21/04 | |
Dipti Amin
BRD | Director/Board Member | 60 | 20/21/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 188,823,975 | 188,001,177 ( 99.56 %) | 0 | 99.56 % |
Company contact information
Lineage Cell Therapeutics, Inc.
2173 Salk Avenue Suite 200
92008-7354, Carlsbad
+442 287 8990
http://www.lineagecell.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+23.13% | 4.69TCr | |
+37.49% | 3.91TCr | |
-8.73% | 3.85TCr | |
+28.09% | 3.1TCr | |
-12.26% | 2.61TCr | |
+10.57% | 2.59TCr | |
+45.05% | 1.42TCr | |
+32.23% | 1.25TCr | |
-6.56% | 1.14TCr |